1-7 of 7
Irene Lurkin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 549: A urine based assay to select patients for initial cystoscopy

Kim E.M. van Kessel, Willemien Beukers, Irene Lurkin, Kirstin A. van der Keur, Lars Dyrskjot, Ulrika Segersten, Torben F. Ørntoft, Nuria Malats, Per-Uno Malmström, Francisco X. Real, Chris H. Bangma, Ellen C. Zwarthoff
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 549.
https://doi.org/10.1158/1538-7445.AM2015-549
Published: 01 August 2015
View article titled, Abstract 549: A urine based assay to select patients for initial cystoscopy
Journal Articles

Abstract P4-02-02: Targeted molecular characterization of serum derived cell free DNA from metastatic breast cancer patients treated with first-line tamoxifen

Maurice Jansen, Corine Beaufort, Jean Helmijr, Ronald van Marion, Niels Krol, Kim Monkhorst, Marian van Fessem, Ron van Schaik, Marcel Smid, Marion Meijer van Gelder, Maxime Look, Anita Trapman, Diana Ramirez-Ardila, Irene Lurkin, Ellen Zwarthoff, John Martens, John Foekens, Winand Dinjens, Stefan Sleijfer, Els Berns
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P4-02-02.
https://doi.org/10.1158/1538-7445.SABCS14-P4-02-02
Published: 01 May 2015
View article titled, Abstract P4-02-02: Targeted molecular characterization of serum derived cell free DNA from metastatic breast cancer patients treated with first-line tamoxifen
Journal Articles

Abstract 2259: Identifying causative genes and prognostic markers for bladder cancer

Angela A.G. Van Tilborg, Jelmar Quist, Lucie C. Kompier, Irene Lurkin, Miriam van Helvoirt, Maximilian Burger, Arndt Hartmann, Ellen C. Zwarthoff
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 2259.
https://doi.org/10.1158/1538-7445.AM2011-2259
Published: 15 April 2011
View article titled, Abstract 2259: Identifying causative genes and prognostic markers for bladder cancer
Journal Articles

Abstract #1644: The development of multiple bladder tumor recurrences in relation to the FGFR3 mutation status of the primary tumor

Lucie Kompier, Angela van Tilborg, Madelon van der Aa, Irene Lurkin, Marcel Vermeij, Wim Kirkels, Chris Bangma, Theo van der Kwast, Ellen Zwarthoff
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 1644.
Published: 01 May 2009
View article titled, Abstract #1644: The development of multiple bladder tumor recurrences in relation to the FGFR3 mutation status of the primary tumor
Journal Articles

The stepwise alteration of chromosome 9 in the evolution of bladder tumors affects predominantly one of the two chromosome copies

Lucie C. Kompier, Irene Lurkin, Ellen C. Zwarthoff
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 987.
Published: 15 April 2006
View article titled, The stepwise alteration of chromosome 9 in the evolution of bladder tumors affects predominantly one of the two chromosome copies
Journal Articles

Evolution of LOH patterns on chromosome 9 in recurrent bladder tumors in relation to a FGFR3 mutation

Lucie C. Kompier, Madelon N. Van der Aa, Latifa Qoubbane, Irene Lurkin, Antoine Van Exsel, Theo H. Van der Kwast, Ellen C. Zwarthoff
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1347.
Published: 01 May 2005
View article titled, Evolution of LOH patterns on chromosome 9 in recurrent bladder tumors in relation to a FGFR3 mutation
Journal Articles

The Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation Is a Strong Indicator of Superficial Bladder Cancer with Low Recurrence Rate

Bas W. G. van Rhijn, Irene Lurkin, François Radvanyi, Wim J. Kirkels, Theodorus H. van der Kwast, Ellen C. Zwarthoff
Journal: Cancer Research
Cancer Res (2001) 61 (4): 1265–1268.
Published: 02 February 2001
View article titled, The Fibroblast Growth Factor Receptor 3 (<em>FGFR3</em>) Mutation Is a Strong Indicator of Superficial Bladder Cancer with Low Recurrence Rate
Open the PDF for The Fibroblast Growth Factor Receptor 3 (<em>FGFR3</em>) Mutation Is a Strong Indicator of Superficial Bladder Cancer with Low Recurrence Rate in another window